Frank Danger Li, MD, agreed to pay $2.9 million to settle allegations that his companies, Seattle Pain Center and Northwest Analytics, billed government payers for medically unnecessary urine drug tests.
According to the settlement agreement, a policy implemented in 2013 required each patient treated at Seattle Pain centers to have a full urine drug panel each time they saw a provider. Dr. Li’s Northwest Analytics did urine testing for the clinics. The policy, which didn’t meet state standards, resulted in thousands of medically unnecessary tests.
Dr. Li’s seven pain clinics closed in July 2016 after Washington state officials suspended his medical license for improperly monitoring opioid prescriptions. The most recent settlement is a civil resolution and unrelated to criminal investigations or state health regulator actions.
More articles on legal and regulatory issues:
Pennsylvania physician charged in patient’s death
Tennessee hospital settles false billing allegations
Feds charge California physician for allegedly selling fake COVID-19 cure
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
